Alveolar type II cell cNOS activity and ATP levels are increased by lung surfactant or DPPC vesicles
P. R. Miles, L. Bowman, A. Rengasamy and L. Huffman Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA. In a previous study, we reported that nitric oxide (.NO) affects surfactant synthesis and ATP levels in alveolar type II cell...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Lung cellular and molecular physiology 1997-08, Vol.273 (2), p.339-L346 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | P. R. Miles, L. Bowman, A. Rengasamy and L. Huffman
Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
In a previous study, we reported that nitric oxide (.NO) affects surfactant
synthesis and ATP levels in alveolar type II cells and suggested that there
is constitutive nitric oxide synthase (cNOS) activity in the cells. In the
present study, we performed experiments to confirm further the presence of
cNOS and to determine the effects of lung surfactant on type II cell .NO
and ATP levels. The supernatant from freshly isolated cells contains .NO
(0.26 +/- 0.08 nmol/10(6) cells). During incubation, the cells produce
additional .NO at a rate of approximately 0.3 nmol.10(5) cells-1.h-1. .NO
formation is inhibited by 28-46% by three inhibitors of cNOS and inducible
NOS (iNOS), NG-monomethyl-L-arginine (L-NMMA), L-N5-(1-iminoethyl)ornithine
hydrochloride, and NG-nitro-L-arginine methyl ester, but a specific
inhibitor of iNOS, aminoguanidine, has no effect. The production of .NO is
reduced in Ca(2+)-free medium, is stimulated by the Ca2+ ionophore A-23187,
and is independent of extracellular L-arginine. One known type of cNOS,
endothelial NOS (eNOS), can be detected in the cells by using Western blot
analysis. Incubation of the cells with lung surfactant leads to a
relatively rapid (approximately 15 min), concentration-dependent increase
in .NO formation that reaches levels as high as 238 +/- 14% of control. The
surfactant effects appear to be caused by its major component, dipalmitoyl
phosphatidylcholine (DPPC). Exposure of type II cells to DPPC results in
maximal increases in .NO formation, ATP content, and O2 consumption, which
are 268 +/- 32, 234 +/- 24, and 131 +/- 6% of control, respectively. The
DPPC-induced increases in .NO, ATP, and O2 consumption are inhibited by
L-NMMA. These results confirm the presence of type II cell cNOS and suggest
that it may have a role in the cellular processing of lung surfactant. |
---|---|
ISSN: | 1040-0605 0002-9513 1522-1504 2163-5773 |
DOI: | 10.1152/ajplung.1997.273.2.l339 |